The Union Budget-2017 proposal to drastically amend the Drugs and Cosmetics Act to enable availability and affordability of cheaper generic drugs to patients is expected to have key impacts on the local drug industry
Read More
Revenue for the quarter ended December 31, 2016 was Rs 504 crore as compared to Rs 521 crore in the same period last year
Read More
Offer worth $280 a share plus one share in new R&D company; New R&D company to develop Actelion experimental drugs
Read More
The pharmaceutical industry has asked the government to bring in more clarity in terms of tax structure and provide incentives on research and development as part of its budget wish-list
Read More
India requires a dual focus on entrepreneurship and innovation, as well as removing the barriers to new investment and improving the overall climate for business
Read More
Reason for selling this new anti-cancer drug by Novartis, which consolidated its global oncology business by acquiring the entire cancer drug portfolio of GlaxoSmithKline (GSK) in a $16 billion global deal in March 2015, is not disclosed
Read More
US-based Baxter International Inc on Thursday entered into a definitive agreement to acquire Claris Injectables, a wholly owned subsidiary of Claris Lifesciences, for approximately $625 million
Read More
The US Food and Drug Administration has again raised concerns about the quality control process at Indian drugmaker Sun Pharmceutical Industries' Halol factory, an inspection report obtained by Reuters shows
Read More
